Table 2.

Acute GVHD characteristics and treatment response by day 180 (n = 56).

Characteristic	Patients
Time to aGVHD onset, n (%)
≥ 100 days	44 (79)
101–180 days	12 (21)
Organ involvement, n (%)
Skin alone	28 (50)
GI	28 (50)
Skin/GI	6 (11)
GI alone	19 (34)
GI/liver	1 (2)
GI/liver/skin	2 (3)
Liver alone	0
aGVHD grade at treatment onset, n (%)
I	17 (30.5)
II	26 (46.5)
III	13 (23)
IV	0
aGVHD treatment, n (%)
Topical corticosteroids	27 (49)
Budesonide	15 (27)
Systemic corticosteroids	13 (24)
No treatment*	1 (2)

aGVHD indicates acute graft-versus-host disease; n, number; GI, gastrointestinal.

^*One patient with aGVHD ≤ day 100 presented leukemia relapse shortly after GVHD diagnosis and did not received any GVHD therapy.